Skip to Main Content

Author Details

Anna Burford
2004
17
13
PMIDPaper TitleJournal TitlePublished Year
37957701Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.2023
35587280Recurrent ACVR1 mutations in posterior fossa ependymoma.Acta Neuropathol2022
32238360Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.Cancer Discov2020
29348602The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.Scientific Reports2018
29967352Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.Nat Med2018
29763623Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.Cancer Cell2018
26957305Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.Molecular Neurobiology2017
28401334H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.Acta Neuropathol2017
28966033Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.Cancer Cell2017
27180091Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.J Neurooncol2016
26597605Adult recurrent pilocytic astrocytoma: Clinical, histopathological and molecular study.Neurochirurgie2015
26514459Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study.2015
23539269Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.Cancer Discov2013
23990986Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.PLoS ONE2013
16437137Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.Leukemia2006
16211545Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.Cancer2005
15381376Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.Cancer Genetics and Cytogenetics2004
  • 1 - 17 of 17

Recommended Authors

Collaborators

Chris Jones
Co-authored papers 12
Sergey Popov
Co-authored papers 9
Alan Mackay
Co-authored papers 8
Maria Vinci
Co-authored papers 6
Saoussen Trabelsi
Co-authored papers 5
Diana Carvalho
Co-authored papers 5
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
Safa Al-Sarraj
Co-authored papers 5
Lynley V Marshall
Co-authored papers 4
Valeria Molinari
Co-authored papers 4
Andrew S Moore
Co-authored papers 4
Matthew Clarke
Co-authored papers 4
Elisa Izquierdo
Co-authored papers 4
Leslie R Bridges
Co-authored papers 4
Christopher Chandler
Co-authored papers 3
Kathryn R Taylor
Co-authored papers 3
Sucheta Vaidya
Co-authored papers 3
Thomas S Jacques
Co-authored papers 3
Ho-Keung Ng
Chinese University of Hong Kong
Co-authored papers 3
Henry Mandeville
Co-authored papers 3
David Capper
Charite University Medicine Berlin
Co-authored papers 3
Andrew J Martin
Co-authored papers 3
Stergios Zacharoulis
Co-authored papers 3
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Co-authored papers 2
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Michael Farrell
Co-authored papers 2
Lynn Bjerke
Co-authored papers 2
Natacha Entz-Werle
Co-authored papers 2
Release 1.2